Join to access to all OVN content. Join for Free

Results for 'AI'

The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients
Partner Avatar Monty Pal
The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients

City of Hope, Monty Pal, John Carpten, genomics, genome mapping, TGen, Translational Genomics Research Institute, spatial biology, AI, access

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, John Carpten, Ph.D., Chief Scientific Officer at City of Hope, discusses the evolution of cancer genomics—how early genome mapping enabled today’s targeted approaches and what infrastructure and equity considerations will…

Mar 23rd • 56 mins listen

Humans Beyond the Algorithm: Hiring for Oncology’s Future
OVN Avatar Kirk Shepard
Humans Beyond the Algorithm: Hiring for Oncology’s Future

Stacy Benefiel, AI, Talent, Workforce Innovation, Human Resources, HR

In episode 4 of Oncology Voice Network Podcast, Host Dr. Kirk Shepard welcomes Stacey Benefiel, PharmD, Head of Global Clinical and Medical Affairs at Canopy, for a candid exploration of what it really takes to build the future oncology workforce.

Mar 3rd • 23 mins listen

The Future of Cancer Surgery: Innovations, AI, and Remote Robotics
Partner Avatar Monty Pal
The Future of Cancer Surgery: Innovations, AI, and Remote Robotics

City of Hope, Monty Pal, Yuman Fong, AI, robotics, surgical oncology, oncolytic virus, remote surgical procedure

Dr. Yuman Fong shares insights on AI, robotics, the future of surgical oncology, plus his groundbreaking work in oncolytic viruses and the importance of mentorship.

Mar 10th • 33 mins listen

Humanizing Cancer Treatment Through Whole-Person Care
Partner Avatar Monty Pal
Humanizing Cancer Treatment Through Whole-Person Care

City of Hope, Monty Pal, Betty Ferrell, palliative care, quality of life, pain management, bone marrow transplantation, Ethiopia

Dr. Betty Ferrell on her global legacy in palliative care and why whole-person treatment is as crucial as fighting cancer itself.

Apr 21st • 47 mins listen

Building the First AI Agent for Cancer Research
Partner Avatar Monty Pal
Building the First AI Agent for Cancer Research

City of Hope, Monty Pal, Enrique Velazquez Villarreal, Latino, colorectal cancer, mentor, genomics, AI, artificial intelligence, multiomic

Dr. Enrique Velazquez Villarreal on AI, genomics, and why young Latinos are at the heart of his work to improve colorectal cancer research and care.

May 5th • 49 mins listen

Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
Partner Avatar Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery

City of Hope, Monty Pal, Walter Stadler, Alan Bryce, ASCO, national model, precision, AI, clinical trial design, dose strategy, early detection, long term survivorship

Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.

Jun 23rd • 43 mins listen

How Team Science is Driving Lung Cancer Breakthroughs
Partner Avatar Monty Pal
How Team Science is Driving Lung Cancer Breakthroughs

City of Hope, Monty Pal, Loretta Erhunmwunsee, lung cancer, thoracic surgeon, air pollution, diversity

Dr. Loretta Erhunmwunsee explores her latest groundbreaking research investigating the impact of air pollution on lung cancer and shares how team science is critical to advancing cancer care for all.

Aug 19th • 32 mins listen

BONUS: The Future of Cancer Surgery: Innovations, AI and Remote Robotics
Partner Avatar Monty Pal
BONUS: The Future of Cancer Surgery: Innovations, AI and Remote Robotics

City of Hope, Yuman Fong, Monty Pal, Surgical Oncology, AI, Remote Robotics, oncoloytic virus, mentor

This is an audience favorite episode. Dr. Yuman Fong shares insights on AI, robotics, the future of surgical oncology, plus his groundbreaking work in oncolytic viruses and the importance of mentorship.

Dec 22nd • 32 mins listen

How to Accelerate Cancer Cures Through Collaboration with Kirk V. Shepard, MD
Partner Avatar Michael Pietrack
How to Accelerate Cancer Cures Through Collaboration with Kirk V. Shepard, MD

Kirk Shepard, Michael Pietrack, mentor, AI, digital

Join host Michael Pietrack on the PharmaVerse Podcast as he speaks with Dr. Kirk Shepard, Chief Medical Officer of PDS Biotechnology, co-founder of the Medical Affairs Professional Society (MAPS), and creator of the Oncology Voices Network (OVN).

Feb 2nd • 24 mins listen

Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
Partner Avatar Monty Pal
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray

City of Hope, Monty Pal, Stacy Gray, precision medicine, germline testing, INSPIRE program, whole body MRI, genomic, tumor board

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are tran…

Feb 23rd • 43 mins listen

Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack
Hiring Managers Beware: Reverse Rejection Explained!

Hiring Managers Beware Reverse Rejection! 👉 This tip is for hiring managers and recruiters out there. There is a defense mechanism that takes place with candidates that we need to be aware of. I call it reverse rejection. Here’s how it works. 👉 Let’s say a candidate has their fir…

Nov 26th • 2 mins listen

The Power of Commercial Leadership in Oncology
OVN Avatar Kirk Shepard
The Power of Commercial Leadership in Oncology

Discover how commercial leadership, collaboration, and clear communication shape success in oncology—and why patients depend on it.  

Mar 17th • 31 mins listen

How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.
Partner Avatar Monty Pal
How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.

City of Hope, Monty Pal, Anna Wu, engineered antibodies, PET, imaging, radioisotope, CEA directed agent, PSCA targeted radiopharmaceutical, pancreatic cancer, prostate cancer

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Anna Wu, Ph.D., Chair of the Department of Immunology and Theranostics at City of Hope, joins host Monty Pal, M.D., for an engaging discussion on how innovations in antibody engineering and imaging are improving clinicians’…

Mar 9th • 42 mins listen

Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Partner Avatar Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing

Quest Diagnostics, Jesus Izaguirre Carbonell, Thoman Slavin, MRD testing, minimal residual testing, precision tool, biomarker, ctDNA, circulating tumor DNA

Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.

Jul 7th • 19 mins listen

Advancing Cancer Survivorship and Cardio-Oncology
Partner Avatar Monty Pal
Advancing Cancer Survivorship and Cardio-Oncology

City of Hope, Monty Pal, Saro Armenian, pediatric, cardio-oncology, CHIP clinic

Dr. Saro Armenian discusses breakthroughs in cancer survivorship, pediatric oncology and City of Hope’s pioneering work in cardio-oncology.

Feb 24th • 39 mins listen

Pushing the Limits of Cancer Research and Surgery
Partner Avatar Monty Pal
Pushing the Limits of Cancer Research and Surgery

City of Hope, Monty Pal, Mustafa Raoof, PIPAC, peritoneal, pancreatic cancer, surgical oncology

Dr. Mustafa Raoof on PIPAC, pancreatic cancer research, and how global innovation can shape the next chapter of surgical oncology.

Apr 7th • 38 mins listen

At the Crossroads of Cancer and Metabolism
Partner Avatar Monty Pal
At the Crossroads of Cancer and Metabolism

City of Hope, Monty Pal, Charles Brenner, metabolism, diabetes, obesity, fatty liver, metabolic dysfunction, GLP-1, FGF21, NAD metabolism

Dr. Charles Brenner explores the metabolic links between cancer, diabetes, NAD, and the future of liver-focused therapies.

Jul 7th • 37 mins listen

Rewriting the Rules of Cellular Therapy
Partner Avatar Monty Pal
Rewriting the Rules of Cellular Therapy

City of Hope, Monty Pal, Stephen Forman, hematologic malignancy, cellular immunotherapy, bone marrow, CAR-T cell therapy

Dr. Stephen Forman shares the past, present, and future of cellular therapy and how City of Hope is building care systems to reach more patients.

Jul 21st • 47 mins listen

Why Genetic Testing Should Be Standard in Prostate Cancer
Partner Avatar Rebecca Previs
Why Genetic Testing Should Be Standard in Prostate Cancer

Labcorp, Rebecca Previs, Sarah Young, genetic counselor, genetic testing, prostate cancer, urologic oncology, germline, somatic, PARP inhibitors, digital

Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.

May 18th • 19 mins listen

Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Partner Avatar Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology

Labcorp, Rebecca Previs, Heidi Ko, HER2, NGS, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker, ERBB2, IHC, FISH, biomarker

What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.

Jun 8th • 20 mins listen

Related Topics

Meet Our Innovation Partners

Loading partners...